期刊名称：PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Journal news
New to Taylor & Francis for 2017
Aims and scope
2016 Impact Factor: 0.495
5-year Impact Factor: 0.425
© 2017 Clarivate Analytics, Journal Citation Reports ®
Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.
Topics of current interest to clinical, experimental and basic scientists are published in critical subjects, such as psychopharmacology, psychiatry and behavioral science. Psychiatry and Clinical Psychopharmacology effectively bridges the gap between basic science and clinical application. Access to the Journal is available to all interested persons with no subscription fees, furthering the aim of reaching all interested national and international associations and individuals.
Psychiatry and Clinical Psychopharmacology was formerly titled Bulletin of Clinical Psychopharmacology from the first volume in 1990 until 2016.
The standard article publishing charge (APC) for this journal is £575 / US$750 / €665. Depending on your location these charges may be subject to local taxes. Once your paper has been assessed for suitability by the editor, it will then be single blind peer-reviewed by independent, anonymous, expert referees.
Publication history
Currently known as:
- Psychiatry and Clinical Psychopharmacology (2016 - current)
Formerly known as
- Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology (2010 - 2016)
Instructions to Authors
This journal uses Editorial Manager to peer review manuscript submissions. Please read the guide for Editorial Manager authors before making a submission. Complete guidelines for preparing and submitting your manuscript to this journal are provided below.
Contents
About the Journal
Psychiatry and Clinical Psychopharmacology is an Open Access international, peer-reviewed journal publishing high-quality, original research. Please see the journal's Aims & Scope for information about its focus and peer-review policy.
Open Access means you can publish your research so it is free to access online as soon as it is published, meaning anyone can read (and cite) your work. Please see our guide to Open Access for more information. Many funders mandate publishing your research open access; you can check open access funder policies and mandates here.
Please note that this journal only publishes manuscripts in English.
Psychiatry and Clinical Psychopharmacology accepts the following types of article:
- original articles
- review articles
- case reports
- editorials
- short communications/brief reports
- letters to editors
Article Publishing Charge
The standard article publishing charge (APC) for this journal is US$750/£575/€665. Depending on your location, these charges may be subject to local taxes.
Find out more about article publishing charges and funding options.
In 2018, Psychiatry and Clinical Psychopharmacology is offering a limited number of free APCs for submissions where the corresponding author resides in Turkey at the time of submission.
Peer Review
Taylor & Francis is committed to peer-review integrity and upholding the highest standards of review. Once your paper has been assessed for suitability by the editor, it will then be single blind peer reviewed by independent, anonymous expert referees. Find out more about what to expect during peer review and read our guidance on publishing ethics.
Preparing Your Paper
All authors submitting to medicine, biomedicine, health sciences, allied and public health journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).
Original articles
- Should be written with the following elements in the following order: title page; abstract; keywords; main text introduction, materials and methods, results, discussion; acknowledgments; declaration of interest statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list)
- Should be between 5000 and 8500 words, inclusive of tables, references, figure captions, footnotes, endnotes.
- Should contain a structured abstract of 500 words.
- No more than 6 keywords. Read making your article more discoverable, including information on choosing a title and search engine optimization.
Review articles
- Should be written with the following elements in the following order: title page; abstract; keywords; main text introduction, materials and methods, results, discussion; acknowledgments; declaration of interest statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list)
- Should be between 3000 and 4500 words, inclusive of tables, references, figure captions, footnotes, endnotes.
- Should contain a structured abstract of 500 words.
- No more than 6 keywords. Read making your article more discoverable, including information on choosing a title and search engine optimization.
Case reports, editorials, short communications/brief reports
- A case report should be more than 1000 and no more than 3500 words; this limit does not include abstract; this limit includes endnotes, footnotes, tables, references, figure captions. A Editorial for this journal should be more than 2500 and no more than 3500 words; this limit does not include abstract; this limit includes tables, references, figure captions, footnotes, endnotes.
letters to editors
- Should be between 500 and 1500 words, inclusive of tables, references, figure captions, footnotes, endnotes.
- Letters to the Editor Letters must include a descriptive title. Most letters to the editor either report cases or small studies or comment on a recent Journal article. For case reports and small studies, ensure that the chronology of events is clear, and specify the month/year in which events occurred. Specify diagnostic criteria used for any diagnoses mentioned, and provide references for scales/assessment tools used. If a search of the literature was conducted for related case reports, specify the data sources, keywords, and any date/language limitations used in the search. Letters reporting small studies typically include (1) a brief introductory paragraph, (2) sections titled "Method" and "Results" (labeled with capitalized headings), and (3) a conclusions/discussion section. Letters reporting cases typically consist of (1) a brief introductory paragraph, (2) description of the cases, and (3) a discussion section. For letters reporting multiple cases, the types of clinical and demographic details given (eg, race, gender, occupation, marital status, medications, follow-up) should be consistent among the cases. It is not necessary to include all of these details in case reports, but if a particular characteristic, eg, occupation, is reported for one case, it should be reported for all of the cases. For letters commenting on a Journal article, include a numbered reference to the article discussed. Be concise, and support your assertions with references as applicable. Also, please note that the authors of the original article will be given the opportunity to reply to letters commenting on their article. Letters may be up to 500 words in length with a maximum of 5 references.
Style Guidelines
Please refer to these quick style guidelines when preparing your paper, rather than any published articles or a sample copy.
Please use American spelling style consistently throughout your manuscript.
Please use double quotation marks, except where “a quotation is ‘within’ a quotation”. Please note that long quotations should be indented without quotation marks.
Papers may be submitted in Word or LaTeX formats. Figures should be saved separately from the text. To assist you in preparing your paper, we provide formatting template(s).
Word templates are available for this journal. Please save the template to your hard drive, ready for use.
A LaTeX template is available for this journal. Please save the LaTeX template to your hard drive and open it, ready for use, by clicking on the icon in Windows Explorer.
If you are not able to use the template via the links (or if you have any other template queries) please contact us here.
References
Please use this reference guide when preparing your paper. An EndNote output style is also available to assist you.
Checklist: What to Include
- Author details. Please ensure everyone meeting the International Committee of Medical Journal Editors (ICMJE) requirements for authorship is included as an author of your paper. All authors of a manuscript should include their full name and affiliation on the cover page of the manuscript. Where available, please also include ORCiDs and social media handles (Facebook, Twitter or LinkedIn). One author will need to be identified as the corresponding author, with their email address normally displayed in the article PDF (depending on the journal) and the online article. Authors’ affiliations are the affiliations where the research was conducted. If any of the named co-authors moves affiliation during the peer-review process, the new affiliation can be given as a footnote. Please note that no changes to affiliation can be made after your paper is accepted. Read more on authorship.
- You can opt to include a video abstract with your article. Find out how these can help your work reach a wider audience, and what to think about when filming.
- Funding details. Please supply all details required by your funding and grant-awarding bodies as follows:
For single agency grants
This work was supported by the [Funding Agency] under Grant [number xxxx].
For multiple agency grants
This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx].
- Disclosure statement. This is to acknowledge any financial interest or benefit that has arisen from the direct applications of your research. Further guidance on what is a conflict of interest and how to disclose it.
- Biographical note. Please supply a short biographical note for each author. This could be adapted from your departmental website or academic networking profile and should be relatively brief (e.g. no more than 200 words).
- Geolocation information. Submitting a geolocation information section, as a separate paragraph before your acknowledgements, means we can index your paper’s study area accurately in JournalMap’s geographic literature database and make your article more discoverable to others. More information.
- Supplemental online material. Supplemental material can be a video, dataset, fileset, sound file or anything which supports (and is pertinent to) your paper. We publish supplemental material online via Figshare. Find out more about supplemental material and how to submit it with your article.
- Figures. Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour, at the correct size). Figures should be supplied in one of our preferred file formats: EPS, PS, JPEG, GIF, or Microsoft Word (DOC or DOCX). For information relating to other file types, please consult our Submission of electronic artwork document.
- Tables. Tables should present new information rather than duplicating what is in the text. Readers should be able to interpret the table without reference to the text. Please supply editable files.
- Equations. If you are submitting your manuscript as a Word document, please ensure that equations are editable. More information about mathematical symbols and equations.
- Units. Please use SI units (non-italicized).
Using Third-Party Material in your Paper
You must obtain the necessary permission to reuse third-party material in your article. The use of short extracts of text and some other types of material is usually permitted, on a limited basis, for the purposes of criticism and review without securing formal permission. If you wish to include any material in your paper for which you do not hold copyright, and which is not covered by this informal agreement, you will need to obtain written permission from the copyright owner prior to submission. More information on requesting permission to reproduce work(s) under copyright.
Disclosure Statement
Please include a disclosure statement, using the subheading “Disclosure of interest.” If you have no interests to declare, please state this (suggested wording: The authors report no conflict of interest). For all NIH/Wellcome-funded papers, the grant number(s) must be included in the declaration of interest statement. Read more on declaring conflicts of interest.
Clinical Trials Registry
In order to be published in a Taylor & Francis journal, all clinical trials must have been registered in a public repository at the beginning of the research process (prior to patient enrolment). Trial registration numbers should be included in the abstract, with full details in the methods section. The registry should be publicly accessible (at no charge), open to all prospective registrants, and managed by a not-for-profit organization. For a list of registries that meet these requirements, please visit the WHO International Clinical Trials Registry Platform (ICTRP). The registration of all clinical trials facilitates the sharing of information among clinicians, researchers, and patients, enhances public confidence in research, and is in accordance with the ICMJE guidelines.
Complying With Ethics of Experimentation
Please ensure that all research reported in submitted papers has been conducted in an ethical and responsible manner, and is in full compliance with all relevant codes of experimentation and legislation. All papers which report in vivo experiments or clinical trials on humans or animals must include a written statement in the Methods section. This should explain that all work was conducted with the formal approval of the local human subject or animal care committees (institutional and national), and that clinical trials have been registered as legislation requires. Authors who do not have formal ethics review committees should include a statement that their study follows the principles of the Declaration of Helsinki.
Consent
All authors are required to follow the ICMJE requirements on privacy and informed consent from patients and study participants. Please confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any research, experiment, or clinical trial described in your paper has given written consent to the inclusion of material pertaining to themselves, that they acknowledge that they cannot be identified via the paper; and that you have fully anonymized them. Where someone is deceased, please ensure you have written consent from the family or estate. Authors may use this Patient Consent Form, which should be completed, saved, and sent to the journal if requested.
Health and Safety
Please confirm that all mandatory laboratory health and safety procedures have been complied with in the course of conducting any experimental work reported in your paper. Please ensure your paper contains all appropriate warnings on any hazards that may be involved in carrying out the experiments or procedures you have described, or that may be involved in instructions, materials, or formulae.
Please include all relevant safety precautions; and cite any accepted standard or code of practice. Authors working in animal science may find it useful to consult the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare and Guidelines for the Treatment of Animals in Behavioural Research and Teaching. When a product has not yet been approved by an appropriate regulatory body for the use described in your paper, please specify this, or that the product is still investigational.
Submitting Your Paper
This journal uses Editorial Manager to manage the peer-review process. If you haven't submitted a paper to this journal before, you will need to create an account in Editorial Manager. Please read the guidelines above and then submit your paper in the relevant Author Centre, where you will find user guides and a helpdesk.
If you are submitting in LaTeX, please convert the files to PDF beforehand (you will also need to upload your LaTeX source files with the PDF).
Please note that Psychiatry and Clinical Psychopharmacology uses Crossref™ to screen papers for unoriginal material. By submitting your paper to Psychiatry and Clinical Psychopharmacology you are agreeing to originality checks during the peer-review and production processes.
On acceptance, we recommend that you keep a copy of your Accepted Manuscript. Find out more about sharing your work.
Copyright Options
Copyright allows you to protect your original material, and stop others from using your work without your permission. Taylor & Francis offers a number of different license and reuse options, including Creative Commons licenses when publishing open access. Read more on publishing agreements.
Complying with Funding Agencies
We will deposit all National Institutes of Health or Wellcome Trust-funded papers into PubMedCentral on behalf of authors, meeting the requirements of their respective open access policies. If this applies to you, please tell our production team when you receive your article proofs, so we can do this for you. Check funders’ open access policy mandates here. Find out more about sharing your work.
Accepted Manuscripts Online
This journal posts manuscripts online as rapidly as possible, as a PDF of the final, accepted (but unedited and uncorrected) paper. This is clearly identified as an unedited manuscript and is referred to as the Accepted Manuscript Online (AMO). No changes will be made to the content of the original paper for the AMO version but, after copy-editing, typesetting, and review of the resulting proof, the final corrected version (the Version of Record [VoR]), will be published, replacing the AMO version.
The VoR is the article in its final, definitive and citable form (this may not be immediately paginated, but is the version that will appear in an issue of the journal). Both the AMO version and VoR can be cited using the same DOI (digital object identifier). To ensure rapid publication, we ask you to return your signed publishing agreement as quickly as possible, and return corrections within 48 hours of receiving your proofs.
My Authored Works
On publication, you will be able to view, download and check your article’s metrics (downloads, citations and Altmetric data) via My Authored Works on Taylor & Francis Online. This is where you can access every article you have published with us, as well as your free eprints link, so you can quickly and easily share your work with friends and colleagues.
We are committed to promoting and increasing the visibility of your article. Here are some tips and ideas on how you can work with us to promote your research.
Article Reprints
You will be sent a link to order article reprints via your account in our production system. For enquiries about reprints, please contact the Taylor & Francis Author Services team at reprints@tandf.co.uk.
Queries
Should you have any queries, please visit our Author Services website or contact us here.
Updated 25-05-2018
Editorial Board
Editor-in-Chief
Mesut Cetin, MD
Turkish Association for Psychopharmacology, Istanbul, Turkey
Academic Editor
Samet Kose, MD, PhD
University of Texas Health Science Center at Houston, Houston, TX, USA
sametkose@gmail.com
Statistics Editor
Cengiz Han Acikel, MD
Gulhane Military Medical Academy, Ankara, Turkey
Evren Tufan, MD
Abant Izzet Baysal Universitesi, Istanbul, Turkey
International Affairs
Feyza Aricioglu, PhD
Marmara Universitesi, Istanbul, Turkey
Glen Baker, PhD, D.Sc
University of Alberta, Edmonton, Alberta, Canada
Serdar Dursun, MD, PhD
University of Alberta, Edmonton, Alberta, Canada
Samet Kose, MD, PhD
University of Texas Health Science Center at Houston, Houston, TX, USA
Dost Ongur, MD
Mclean Hospital, Belmont, MA, USA
David Osser, MD, PhD
Brockton VA Medical Center, Boston, MA, USA
International Consultant to the Chief Editor
Judith Baker, PhD
University of Alberta, Edmonton, Alberta, Canada
Samet Kose, MD, PhD
University of Texas Health Science Center at Houston, Houston, TX, USA
Technical Staff
Ozlem Cakiroglu
Yeditepe University, Istanbul, Turkey
Ertugrul Yasar
Istanbul University, Istanbul, Turkey
International Advisory Board
Cengiz Han Acikel, MD
Gulhane Military Medical Academy, Ankara, Turkey
Dov Aizenberg, MD
Rabin Medical Center, Tel Aviv, Israel
Ayhan Algul, MD
Gulhane Military Medical Academy, Istanbul, Turkey
Koksal Alptekin, MD
Dokuz Eylul Universitesi, Izmir, Turkey
Irem Anli, PhD,
Istanbul Bilim Universitesi, Istanbul, Turkey/p>
Feyza Aricioglu, PhD
Marmara Universitesi, Istanbul, Turkey
Murad Atmaca, MD
Firat Universitesi, Elazig, Turkey
Omer Aydemir, MD
Atatürk State Hospital, Izmir, Turkey
Nazan Aydin, MD
Bakirkoy Mental Diseases Education Hospital, Istanbul, Turkey
Glen Baker, PhD, D.Sc
University of Alberta, Edmonton, Alberta, Canada
David Baldwin, MD
University of Southampton, Southampton, UK
Michel Bourin, MD, PhD
University of Nantes, Nantes, France
Charles Bowden, MD, PhD
UT Health San Antonio, San Antonio, TX, USA
Birgul Elbozan Cumurcu, MD
Inonu Universitesi, Malatya, Turkey
Feryal Cam Celikel, MD
Isik Universitesi, Istanbul, Turkey
Mesut Cetin, MD
Turkish Association for Psychopharmacology, Istanbul, Turkey
Jeong-Ho Chae, MD
Catholic University of South Korea, Seoul, South Korea
Yuan-Hwa Chou, MD
National Yang-Ming University, Taipei, Taiwan
Serhat Citak, MD, PhD
Istanbul Medeniyet Universitesi, Istanbul, Turkey
C. Robert Cloninger, MD
Washington University, St. Louis, MO, USA
John Cookson, MD
Royal London Hospital, London, UK
Hakan Coskunol, MD
Ege University, Izmir, Turkey
Asli Enez Darcin, MD
Kanuni SS Training and Research Hospital, Istanbul, Turkey
Bill Deakin, MD
University of Manchester, Manchester, UK
Melissa Delbello, MD
University of Cincinnati Medical Center, Cincinnati, OH, USA
Nesrin Dilbaz, MD
Üsküdar University, Istanbul, Turkey
Rasim Somer Diler, MD
University of Pittsburgh, Pittsburgh, PA, USA
Mehmet E. Dokucu, MD. PhD
Northwestern University, Chicago, IL, USA
Serdar Dursun, MD, PhD
University of Alberta, Edmonton, Alberta, Canada
Jon Elhai, PhD
University of Toledo, Toledo, Ohio, USA
Neslihan Emiroglu, MD
Dokuz Eylul University, Izmir, Turkey
Aygun Ertugrul, MD
Hacettepe University Hospitals, Ankara, Turkey
Cuneyt Evren, MD
Bakirkoy Mental Diseases Education Hospital, Istanbul, Turkey
Erol Goka, MD
Ankara Numune Training and Research Hospital, Ankara, Turkey
Ali Saffet Gonul, MD
Ege University, Izmir, Turkey
Andrew Greenshaw, MD, PhD
University of Alberta, Edmonton, Alberta, Canada
Vahdet Gormez, MD
Bezmialem Vakif Universitesi, Istanbul, Turkey
Aynur Gormez, MD
Vakıf University, Istanbul, Turkey
Nicol Ferrier, MD
Newcastle University. Newcastle, UK
David Greenberg, MD
Herzog Hospital, Tel Aviv, Israel
Guy Goodwin, MD
University of Oxford, Oxford, UK
Kyooseob Ha, MD
Seoul National University Bundang Hospital, Seoul, South Korea
Peter Haddad, MD
Greater ManchesterWest Mental Health NHS Foundation Trust, Manchester, UK
Jaime E. C. Hallak, MD, PhD
University of São Paulo, Sao Paulo, Brazil
Cicek Hocaoglu, MD
Recep Tayyip Erdoğan Üniversitesi, Rize, Turkey
Hans W. Hoek, MD, PhD
Parnassia Psychiatric Institute, Groningen, Netherlands
Cyril Hoschl, PhD
University and Prague, Prague, Czech Republic
Kazutaka Ikeda, PhD
Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
Rene S. Kahn, MD
University Medical Center Utrecht, Utrecht, Netherlands
Shigenobu Kanba, MD
Kyushu University, Fukuoka, Japan
Ayse Sakalli Kani, MD
Marmara Universitesi, Istanbul, Turkey
Masaki Kato, MD, PhD
Kansai Medical University, Moriguchi, Japan
Ozge Kilic, MD
Koc University Hospital, Istanbul, Turkey
Ismet Kirpinar, MD
Bezmiâlem Vakif University, Istanbul, Turkey
Oguz Karamustafalioglu, MD
Istanbul University, Istanbul, Turkey
Samet Kose, MD, PhD
University of Texas Health Science Center at Houston, Houston, TX, USA
Andrew Kozel, MD, MSCR
University of South Florida, Tampa, FL, USA
Filiz Kulacaoglu, MD
Hinis State Hospital, Erzurum, Turkey
Isin Baral Kulaksizoglu, MD
Istanbul University, Istanbul, Turkey
Stan Kutcher, MD, PhD
Dalhousie University, Nova Scotia, Canada
Brian Leonard, PhD
Ludwig-Maximilians-University, Munich, Germany
Stefan Leucht, MD
Technical University of Munich, Munich, Germany
Xin-Min Li, MD., PhD, FRCPC
University of Alberta, Edmonton, Alberta, Canada
Jeffrey P. Lorberbaum, MD
Private Practice, Chapel Hill, NC, USA
Peter R. Martin, MD
Vanderbilt Addiction Center, Nashville, TN, USA
Herbert Meltzer, MD, PhD
Northwestern University, Chicago, IL, USA
Pavel Mohr, PhD
Charles University, Prague, Czech Republic
Norbert Muller, MD
Munich University Hospital, Munich, Germany
Hugh Myrick, MD
Medical University of South Carolina, Charleston, SC, USA
Ziad Nahas, MD
American University of Beirut Medical Center, Beirut, Lebanon
Andrew Nierenberg, MD, PhD
Massachusetts General Hospital, Boston, MA, USA
David Nutt, MD
University of Bristol, Bristol, UK
Oguz Omay, MD
La Teppe Medical Center, Tain L’Hermitage, France
Dost Ongur, MD
Mclean Hospital, Belmont, MA, USA
Timucin Oral, MD
Private Practice, Istanbul, Turkey
Jim Van Os, MD
Maastricht University, Maastricht, Netherlands
David Osser, MD, PhD
Harvard Medical School, Brockton, MA, USA
Mucahit Ozturk, MD
Private Practice, Istanbul, Turkey
Aynur Pekcanlar, MD
Dokuz Eylul Universitesi, Izmir, Turkey
Anthony Phillips, PhD, F.R.S.C.
University of British Columbia, British Columbia, Canada
Andres J. Pumariega, MD
Cooper Medical School, Camden, New Jersey, USA
Jorge A. Quiroz, MD, PhD
Solid Biosciences, New York, NY, USA
Trevor W. Robbins, F.R.S.
University of Cambridge, Cambridge, UK
Gary Sachs, MD, PhD
Massachusetts General Hospital, Boston, MA, USA
Gokben Hizli Sayar, MD
Uskudar Universitesi, Istanbul, Turkey
Kemal Sayar, MD
Marmara Universitesi, Istanbul, Turkey
Bengi Semerci, MD
Hasan Kalyoncu Universitesi, Istanbul, Turkey
Guzin M. Sevincer, MD
Gelisim Üniversitesi, Istanbul, Turkey
Baron Short, MD
Medical University of South Carolina, Charleston, SC, USA
Thomas G. Shulze, MD
University Medical Center, Bonn, Germany
Jair Soares, MD, PhD
McGovern Medical School, Houston, TX, USA
Constantin R. Soldatos, MD
University of Athens, Athens, Greece
Mustafa Solmaz, MD
Bagcilar Education And Research Hospital, Istanbul, Turkey
Scott Stuart, MD
University of Iowa Hospitals and Clinics, Iowa City, IA, USA
Mehmet Zihni Sungur, MD
Turkish Association for Cognitive and Behavioural Therapies, Istanbul, Turkey
Sarper Taskiran, MD
University of Kansas School of Medicine, Kansas City, KS, USA
Rajiv Tandon, MD
University of Florida, Gainesville, FL, USA
Tahir Tellioglu, MD
Brown University Warren Alpert Medical School, Providence, RI, USA
Isik Tuglular, PhD
Ege University, Izmir, Turkey
Serhat Tunc, MD
Istanbul Medeniyet Universitesi, Kars, Turkey
Tayfun Turan, MD
Erciyes University, Kayseri, Turkey
Hakan Turkcapar, MD, PhD
Hasan Kalyoncu Universitesi, Istanbul, Turkey
Alp Ucok, MD
Istanbul Universitesi, Istanbul, Turkey
Ozcan Uzun, MD
Gulhane Medical School, Ankara, Turkey
Shigeto Yamawaki, MD
Hiroshima University, Hiroshima, Japan
Elif Anil Yagcioglu, MD
Hacettepe University, Ankara, Turkey
Yanki Yazgan, MD
Marmara University School of Medicine, Istanbul, Turkey
Kazim Yazici, MD
Hacettepe University, Ankara, Turkey
Mesut Yildiz, MD
Marmara Universitesi, Istanbul, Turkey
Ayşegül Yildiz, MD
Dokuz Eylul University, Izmir, Turkey
Mustafa Yildiz, MD
Kocaeli University School of Medicine, Kocaeli, Turkey
Rabia Nazik Yuksel, MD
Bakirkoy Teaching Hospital for Psychiatry, Neurology and Neurosurgery, Ankara, Turkey
Hazli Zakaria, MD
National University of Malaysia, Kuala Lumpur, Malaysia
Joseph Zohar, MD, PhD
Sheba Academic Medical Center Hospital, Tel Aviv, Israel
|
